Meeting
2023 ASCO Annual Meeting
Genomic comparison of MET exon 14 skipping and MET amplified non-small cell lung cancer.
Authors
Rachel Minne
Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, WI
Rachel Minne , Natalie Luo , Anne M. Traynor , Minxuan Huang , Luisina De Tullio , Jen Godden , Melissa Conrad Stoppler , Randall J. Kimple , Andrew Baschnagel
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Local-Regional Non–Small Cell Lung Cancer
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 8553)
DOI
10.1200/JCO.2023.41.16_suppl.8553
Abstract #
8553
Poster Bd #
180
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Prevalence of hyperprogressive disease (HPD) mutations and correlations to immune-related biomarkers in a large pan-cancer Chinese cohort.
First Author: Shengli Yang
Poster
2023 ASCO Annual Meeting
The genomic, transcriptomic, and immunological landscape of SGLT2 in lung cancer.
First Author: Heng Tan
Poster
2022 ASCO Annual Meeting
Differential prognostic effect of systemic inflammation in patients with NSCLC treated with immunotherapy or chemotherapy: A post hoc analysis of the phase III OAK trial.
First Author: Alessio Cortellini
Poster
2021 ASCO Annual Meeting
Genomic and immunologic characterization of large-cell neuroendocrine carcinoma of the lung.
First Author: Chul Kim